Home > News > Top Stories > Presidium Health Deploys Health Gorilla to Access Patient Data in a Direct-To-Home Healthcare Solution

Health Technology, Medical Devices

Presidium Health Deploys Health Gorilla to Access Patient Data in a Direct-To-Home Healthcare Solution

Presidium Health Deploys Health

Health Gorilla, a leading Health Information Network and interoperability provider, is pleased to announce that Presidium Health, the leading mobile healthcare company for medically complex patients, has successfully deployed its EHR data retrieval solution to power complex home care services.

Founded in 2017, Presidium Health provides home-based, whole-person care to the top 1 percent of the most medically and socially complex Medicaid and Medicare beneficiaries. With plans to expand their value-based services nationwide, Presidium successfully deployed their care delivery platform with Health Gorilla’s Patient360 API, which provides access to comprehensive patient data from a nationwide network of sources.

In their search for a data exchange vendor, Presidium Health considered several potential options, including data integration vendors or connecting with health information exchanges directly. Presidium selected Health Gorilla for three main reasons

  • Direct connections into multiple national exchanges (instead of using bridge connections).
  • Leverage of modern standards such as FHIR.
  • Seamless API integration experience and synchronized patient registration.

Presidium is also making use of Health Gorilla’s intuitive user interface (UI), which synchronizes patient registration with their own system. Additionally, Health Gorilla’s document filtering capabilities have become instrumental in removing redundancy and streamlining information for physicians.

“Organized patient data helps us bring whole-person healthcare to our patients 24/7, 365 days a year, wherever they call home,” says Laurent Bortolamiol, Vice President of Technology, Presidium Health. “Health Gorilla’s Patient360 is the solution we have been looking for, enabling the real-time retrieval of comprehensive data on our patients.”

Health Gorilla’s dedicated support team has also been a key asset in this successful collaboration, offering continuous assistance and multiple sandbox environments that match Presidium’s development, testing, demo, and production requirements.

“Presidium Health is dedicated to improving patient care and driving healthcare innovation,” says Steve Yaskin, CEO, Health Gorilla. “With Health Gorilla, Presidium’s providers can access patient records, making it possible for them to deliver care in the comfort of a patient’s home. We are honored to be part of their transformative journey.”

The partnership between Presidium Health and Health Gorilla marks a significant step forward in leveraging nationwide health information exchange to deliver better patient care. Health Gorilla is proud to contribute to Presidium Health’s mission of serving complex patients across the country with efficiency and compassion.

About Health Gorilla

Health Gorilla is a secure health data sharing platform, powering national health information exchange while protecting patient data privacy and security. Health Gorilla provides access to the broadest network of real-time healthcare data sources in the U.S., making it easy for authorized users to get a complete view of their patients. Through our collaborations with healthcare providers, insurers, and government organizations, we play a vital role in improving health outcomes, reducing administrative inefficiencies, and unlocking new business models. Health Gorilla is also one of the applicants accepted for onboarding as a candidate Qualified Health Information Network and must successfully complete testing and onboarding before official designation as a QHIN. Our platform hosts innovative privacy technologies designed to safeguard health data and protect patient privacy.s/sigma-lithium-ships-30-000-tonnes-of-battery-grade-lithium-and-by-products-achieves-net-zero-carbon-operating-profitability-and-premium-pricing-301885762.html

Spotlight

More featured news

Spotlight

Related News

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Read More

Health Technology

Alameda Healthcare Group and Medtronic Unveil Neuroscience Center

Medtronic | November 08, 2023

Alameda Healthcare Group, in partnership with Medtronic, has launched a Neuroscience Center of Excellence to enhance patient care in Egypt and nearby areas. This initiative introduces the StealthStation S8 Surgical Navigation System to revolutionize surgical procedures and enhance clinical outcomes. The Alameda-Medtronic partnership is set to enhance patient care, aligning with Alameda's mission to improve healthcare and solidifying its pioneering role. Alameda Healthcare Group, a premier private healthcare service provider in Egypt, has announced the inauguration of its Neuroscience Center of Excellence, a collaborative effort with Medtronic, a renowned leader in healthcare technology solutions. At the inauguration of the Neuroscience Center of Excellence, esteemed speakers elaborated on the significant role anticipated for the StealthStation S8 Surgical Navigation System in advancing the field of neurosurgery. Meanwhile, Dr. Ramy Amin, Professor of Neurosurgery at Cairo University, led a panel discussion during the launch event. The panel also featured some of the renowned medical consultants, leading neurosurgeons, as well as neurologists. Additionally, Professor Hossam Salah, the Dean of the Faculty of Medicine at Cairo University, graced the event as the guest of honor. The panel discussion explored the pivotal role that this new center is poised to play in enhancing key aspects of neurosurgery. It also commended Alameda's dedication to elevating the quality of patient care through the integration of innovative technology. Neeraj Mishra, Group CEO of Alameda Healthcare, remarked. This partnership represents a substantial step forward in setting new standards for healthcare excellence in Egypt, and we look forward to the benefits it will bring to the patients Alameda continues to serve. [Source – Zawya] He also stated that establishing the Neuroscience Center of Excellence shows Alameda's commitment to advancing technology and raising healthcare standards in Egypt and the surrounding region. With this strategic partnership, Alameda Healthcare Group can incorporate Medtronic's advanced technology into its new center of excellence, thereby bringing about a substantial enhancement in surgical procedures and ultimately improving patient outcomes. Through real-time tracking and advanced imaging capabilities, this technology will enable neurosurgeons to steer complex surgical procedures with heightened precision, thereby enhancing patient results. It will also provide surgeons with various advanced features, including precise imaging, guidance, and different essential surgical tools. The partnership between Alameda Healthcare Group and Medtronic will provide patients with advanced, precise, and patient-focused surgical care. This perfectly aligns with Alameda's mission to improve healthcare for everyone, reinforcing its position as a pioneer in the healthcare industry.

Read More

Health Technology, Digital Healthcare

HARMAN Launches New Private Large Language Model for Healthcare Industry- HARMAN HealthGPT

Business Wire | October 16, 2023

HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer, and enterprise markets, announced that its Digital Transformation Solutions business unit has launched the groundbreaking Healthcare Private Language Model (LLM), known as HealthGPT. HealthGPT represents a leap in healthcare solutions by leveraging generative AI to empower healthcare professionals, researchers, and institutions through advanced patient care, medical research, and decision-making. HealthGPT brings forward all the benefits of a LLM like natural language interaction and learnability, with a strong knowledge base established from a variety of healthcare data sets. The model, built using the key principles of responsible AI, has additionally been tested for accuracy and hallucinations using HARMAN’s own automated LLM testing framework and the results were further validated by the healthcare subject matter experts. HARMAN HealthGPT is a private LLM, providing enterprises with more control over roadmap, privacy, compliance and security issues at optimized cost. Key advantages of working with HARMAN HealthGPT include Enhanced Clinical Insights: Provides real-time, context-aware clinical insights, aiding in decision making. End-to-end LLM Fine tuning framework: A comprehensive framework for fine-tuning Language Model (LLM) to achieve optimal performance. Data generation framework: A framework for creating high quality customized datasets to further fine-tune Language Model (LLM) for enhanced performance. Automated LLM evaluation framework: Completely automated solution to validate fine-tuned LLMs for quality of outputs, factual correctness, hallucinations, and toxicity. Cost Optimization: Advanced deployment techniques using quantization to significantly reduce model size and thereby processing costs by up to one-tenth. Drug Discovery and Research: Accelerate drug discovery and development by extracting valuable insights from clinical trial data. Nick Parrotta, President – Digital Transformation Solutions & Chief Digital and Information officer at HARMAN said, The business value of generative AI cannot be overstated. Organizations that scale and implement swiftly will see significant competitive advantages, productivity gains and more – but only if they can unlock their data and move from general purpose applications to more specialized, domain-specific applications. At HARMAN, it is our mission to help our clients navigate this hurdle and create a competitive advantage long-term. HARMAN HealthGPT is an example of our capabilities that will help organizations utilize specific industry trained models to better solve unique problems and add value for customers. With our long-standing AI expertise and ability to develop effective LLMs, we’re equipped to help our clients move past challenging roadblocks and fully capitalize on the exciting promise of generative AI. [Source – Business Wire] HARMAN is seeing strong early results of the LLM training, and its AI and ML teams are well positioned with an end-to-end, tested framework to fine-tune more private LLMs, beyond the healthcare industry, to solve similar customer problems.

Read More

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Read More

Health Technology

Alameda Healthcare Group and Medtronic Unveil Neuroscience Center

Medtronic | November 08, 2023

Alameda Healthcare Group, in partnership with Medtronic, has launched a Neuroscience Center of Excellence to enhance patient care in Egypt and nearby areas. This initiative introduces the StealthStation S8 Surgical Navigation System to revolutionize surgical procedures and enhance clinical outcomes. The Alameda-Medtronic partnership is set to enhance patient care, aligning with Alameda's mission to improve healthcare and solidifying its pioneering role. Alameda Healthcare Group, a premier private healthcare service provider in Egypt, has announced the inauguration of its Neuroscience Center of Excellence, a collaborative effort with Medtronic, a renowned leader in healthcare technology solutions. At the inauguration of the Neuroscience Center of Excellence, esteemed speakers elaborated on the significant role anticipated for the StealthStation S8 Surgical Navigation System in advancing the field of neurosurgery. Meanwhile, Dr. Ramy Amin, Professor of Neurosurgery at Cairo University, led a panel discussion during the launch event. The panel also featured some of the renowned medical consultants, leading neurosurgeons, as well as neurologists. Additionally, Professor Hossam Salah, the Dean of the Faculty of Medicine at Cairo University, graced the event as the guest of honor. The panel discussion explored the pivotal role that this new center is poised to play in enhancing key aspects of neurosurgery. It also commended Alameda's dedication to elevating the quality of patient care through the integration of innovative technology. Neeraj Mishra, Group CEO of Alameda Healthcare, remarked. This partnership represents a substantial step forward in setting new standards for healthcare excellence in Egypt, and we look forward to the benefits it will bring to the patients Alameda continues to serve. [Source – Zawya] He also stated that establishing the Neuroscience Center of Excellence shows Alameda's commitment to advancing technology and raising healthcare standards in Egypt and the surrounding region. With this strategic partnership, Alameda Healthcare Group can incorporate Medtronic's advanced technology into its new center of excellence, thereby bringing about a substantial enhancement in surgical procedures and ultimately improving patient outcomes. Through real-time tracking and advanced imaging capabilities, this technology will enable neurosurgeons to steer complex surgical procedures with heightened precision, thereby enhancing patient results. It will also provide surgeons with various advanced features, including precise imaging, guidance, and different essential surgical tools. The partnership between Alameda Healthcare Group and Medtronic will provide patients with advanced, precise, and patient-focused surgical care. This perfectly aligns with Alameda's mission to improve healthcare for everyone, reinforcing its position as a pioneer in the healthcare industry.

Read More

Health Technology, Digital Healthcare

HARMAN Launches New Private Large Language Model for Healthcare Industry- HARMAN HealthGPT

Business Wire | October 16, 2023

HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer, and enterprise markets, announced that its Digital Transformation Solutions business unit has launched the groundbreaking Healthcare Private Language Model (LLM), known as HealthGPT. HealthGPT represents a leap in healthcare solutions by leveraging generative AI to empower healthcare professionals, researchers, and institutions through advanced patient care, medical research, and decision-making. HealthGPT brings forward all the benefits of a LLM like natural language interaction and learnability, with a strong knowledge base established from a variety of healthcare data sets. The model, built using the key principles of responsible AI, has additionally been tested for accuracy and hallucinations using HARMAN’s own automated LLM testing framework and the results were further validated by the healthcare subject matter experts. HARMAN HealthGPT is a private LLM, providing enterprises with more control over roadmap, privacy, compliance and security issues at optimized cost. Key advantages of working with HARMAN HealthGPT include Enhanced Clinical Insights: Provides real-time, context-aware clinical insights, aiding in decision making. End-to-end LLM Fine tuning framework: A comprehensive framework for fine-tuning Language Model (LLM) to achieve optimal performance. Data generation framework: A framework for creating high quality customized datasets to further fine-tune Language Model (LLM) for enhanced performance. Automated LLM evaluation framework: Completely automated solution to validate fine-tuned LLMs for quality of outputs, factual correctness, hallucinations, and toxicity. Cost Optimization: Advanced deployment techniques using quantization to significantly reduce model size and thereby processing costs by up to one-tenth. Drug Discovery and Research: Accelerate drug discovery and development by extracting valuable insights from clinical trial data. Nick Parrotta, President – Digital Transformation Solutions & Chief Digital and Information officer at HARMAN said, The business value of generative AI cannot be overstated. Organizations that scale and implement swiftly will see significant competitive advantages, productivity gains and more – but only if they can unlock their data and move from general purpose applications to more specialized, domain-specific applications. At HARMAN, it is our mission to help our clients navigate this hurdle and create a competitive advantage long-term. HARMAN HealthGPT is an example of our capabilities that will help organizations utilize specific industry trained models to better solve unique problems and add value for customers. With our long-standing AI expertise and ability to develop effective LLMs, we’re equipped to help our clients move past challenging roadblocks and fully capitalize on the exciting promise of generative AI. [Source – Business Wire] HARMAN is seeing strong early results of the LLM training, and its AI and ML teams are well positioned with an end-to-end, tested framework to fine-tune more private LLMs, beyond the healthcare industry, to solve similar customer problems.

Read More

More featured news